Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control

Abstract This paper reviews chromatographic screening procedures for simultaneous detection of several drug classes relevant to clinical and forensic toxicology or doping control in urine or blood using gas chromatography-mass spectrometry (GC-MS), liquid chromatography coupled with a diode-array detector (LC-DAD) or a mass spectrometer (LC-MS). The pros and cons of the different techniques and procedures are discussed leading to the following conclusions and perspectives. GC-MS, especially in the electron ionization full-scan mode, is still the method of choice for comprehensive screening providing best separation power, specificity and universality, although requiring derivatization. LC-DAD is also often used for screening, but its separation power and its specificity are still inferior to those of GC-MS. Finally, LC-MS has shown to be an ideal supplement, especially for the detection of more polar, thermolabile and/or low-dose drugs, especially in blood plasma. It may become the gold standard in clinical and forensic toxicology and doping control if, at a later date, the costs of the apparatus will be markedly reduced, the current disadvantages like irreproducibility of fragmentation, reduction of ionization by matrix, etc. will be overcome, and finally if one of the increasing number of quite different techniques will become the apparatus standard.

[1]  S. Dahl,et al.  High‐Performance Liquid Chromatographic Determination of Levomepromazine (Methotrimeprazine) and Its Main Metabolites in Serum and Urine , 1990, Therapeutic drug monitoring.

[2]  M. Thevis,et al.  Liquid chromatography/electrospray ionization tandem mass spectrometric screening and confirmation methods for beta2-agonists in human or equine urine. , 2003, Journal of mass spectrometry : JMS.

[3]  T. Yano,et al.  A Rapid and Simultaneous Determination of Several Analgesic Antiinflammatory Agents by Capillary Zone Electrophoresis , 2003, Therapeutic drug monitoring.

[4]  D. Deforce,et al.  Simultaneous, quantitative determination of opiates, amphetamines, cocaine and benzoylecgonine in oral fluid by liquid chromatography quadrupole-time-of-flight mass spectrometry. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[5]  F. Musshoff,et al.  Fully automated determination of amphetamines and synthetic designer drugs in hair samples using headspace solid-phase microextraction and gas chromatography-mass spectrometry. , 2002, Journal of Chromatographic Science.

[6]  A. Negrusz,et al.  Determination of drugs of abuse in meconium. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[7]  F. Peters,et al.  Prevalence of illicit drug use in plasmapheresis donors , 2003, Vox sanguinis.

[8]  H. Maurer,et al.  Mass spectral and GC data of drugs, poisons, and their metabolites , 1985 .

[9]  Roland F Staack,et al.  Chemistry, Pharmacology, Toxicology, and Hepatic Metabolism of Designer Drugs of the Amphetamine (Ecstasy), Piperazine, and Pyrrolidinophenone Types: A Synopsis , 2004, Therapeutic drug monitoring.

[10]  J. Hirschfeld Conceptual Framework Shifts in Immunogenetics , 1978 .

[11]  F. Peters,et al.  Screening, library-assisted identification and validated quantification of fifteen neuroleptics and three of their metabolites in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization. , 2003, Journal of mass spectrometry : JMS.

[12]  H. Maurer,et al.  Toxicological detection of the new designer drug 1-(4-methoxyphenyl)piperazine and its metabolites in urine and differentiation from an intake of structurally related medicaments using gas chromatography-mass spectrometry. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[13]  W. Weinmann,et al.  LC-MS-MS analysis of the neuroleptics clozapine, flupentixol, haloperidol, penfluridol, thioridazine, and zuclopenthixol in hair obtained from psychiatric patients. , 2002, Journal of analytical toxicology.

[14]  W. Weinmann,et al.  Ion suppression effects in liquid chromatography-electrospray-ionisation transport-region collision induced dissociation mass spectrometry with different serum extraction methods for systematic toxicological analysis with mass spectra libraries. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[15]  M. Bogusz,et al.  Applicability of various brands of mixed-phase extraction columns for opiate extraction from blood and serum. , 1996, Journal of chromatography. B, Biomedical applications.

[16]  H. Maurer,et al.  Screening procedures for simultaneous detection of several drug classes used for high throughput toxicological analyses and doping control. A review. , 2000, Combinatorial chemistry & high throughput screening.

[17]  E. Vuori,et al.  Quantitative screening for benzodiazepines in blood by dual-column gas chromatography and comparison of the results with urine immunoassay. , 2000, Journal of analytical toxicology.

[18]  R. Ventura,et al.  Validation of qualitative chromatographic methods: strategy in antidoping control laboratories. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[19]  P. Marquet,et al.  Comparison of a preliminary procedure for the general unknown screening of drugs and toxic compounds using a quadrupole-linear ion-trap mass spectrometer with a liquid chromatography-mass spectrometry reference technique. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[20]  A. Verstraete,et al.  Detection Time of Drugs of Abuse in Urine , 2000, Acta clinica Belgica.

[21]  H. Maurer,et al.  Studies on the metabolism and toxicological detection of the new designer drug N-benzylpiperazine in urine using gas chromatography-mass spectrometry. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[22]  H. Maurer,et al.  Piperazine-derived designer drug 1-(3-chlorophenyl)piperazine (mCPP): GC-MS studies on its metabolism and its toxicological detection in rat urine including analytical differentiation from its precursor drugs trazodone and nefazodone. , 2003, Journal of analytical toxicology.

[23]  P. Marquet,et al.  Multiresidue determination method for organophosphorus pesticides in serum and whole blood by gas chromatography-mass-selective detection. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[24]  O. Drummer,et al.  LC-MS analysis of serotonergic drugs. , 2003, Journal of analytical toxicology.

[25]  H. Maurer,et al.  Amphetamine-derived Designer Drugs: Metabolism and Screening Procedures/Amphetamin-verwandte Designer-Drogen: Metabolismus und Screening Verfahren , 2002 .

[26]  A. Pacchioni,et al.  Use of High-Performance Liquid Chromatography With Diode-Array Detection After a Primary Drug Screening in Patients Admitted to the Emergency Department , 2003, Therapeutic drug monitoring.

[27]  P. Marriott,et al.  Application of comprehensive two-dimensional gas chromatography to drugs analysis in doping control. , 2003, Journal of chromatography. A.

[28]  H. Maurer,et al.  Studies on the Human Metabolism and the Toxicologic Detection of the Cough Suppressant Dropropizine in Urine Using Gas Chromatography-Mass Spectrometry , 2004, Therapeutic drug monitoring.

[29]  F. Peters,et al.  New designer drug 4'-methyl-alpha-pyrrolidinohexanophenone: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[30]  R. Kronstrand,et al.  Evaluation of electrospray ionisation liquid chromatography-tandem mass spectrometry for rational determination of a number of neuroleptics and their major metabolites in human body fluids and tissues. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[31]  Bogusz Maciej Liquid Chromatography/Mass Spectrometry in Forensic Toxicology , 2003 .

[32]  C. Casari,et al.  Application of solvent microextraction to the analysis of amphetamines and phencyclidine in urine. , 2001, Forensic science international.

[33]  E. Vuori,et al.  Screening for basic drugs in 2-mL urine samples by dual-plate overpressured layer chromatography and comparison with gas chromatography-mass spectrometry. , 2003, Journal of analytical toxicology.

[34]  D. Cooper,et al.  Development of a rapid and sensitive method for the quantitation of amphetamines in human plasma and oral fluid by LC-MS-MS. , 2003, Journal of analytical toxicology.

[35]  H. Kupferschmidt,et al.  Tödliches Hirnödem nach Einnahme von Ecstasy und Benzylpiperazin , 2001 .

[36]  H. Maurer,et al.  Screening for Detection of New Antidepressants, Neuroleptics, Hypnotics, and Their Metabolites in Urine by GC-MS Developed Using Rat Liver Microsomes , 2001, Therapeutic drug monitoring.

[37]  M. Bogusz,et al.  Liquid chromatography-mass spectrometry as a routine method in forensic sciences: a proof of maturity. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[38]  H. Maurer,et al.  New designer drug p-methoxymethamphetamine: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[39]  H. Maurer,et al.  Identification of cytochrome p450 enzymes involved in the metabolism of 4'-methyl-alpha-pyrrolidinopropiophenone, a novel scheduled designer drug, in human liver microsomes. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[40]  E. Vuori,et al.  Simultaneous screening and quantitation of 18 antihistamine drugs in blood by liquid chromatography ionspray tandem mass spectrometry. , 2001, Forensic science international.

[41]  H. Thompson,et al.  Trace level determination of doxylamine in nonhuman primate plasma and urine by GC/NPD and HPLC. , 1984, Journal of Analytical Toxicology.

[42]  R. Glennon,et al.  Further evidence for an amphetamine-like mechanism of action of the alkaloid cathinone. , 1986, Biochemical pharmacology.

[43]  C. Jurado,et al.  Rapid analysis of amphetamine, methamphetamine, MDA, and MDMA in urine using solid-phase microextraction, direct on-fiber derivatization, and analysis by GC-MS. , 2000, Journal of analytical toxicology.

[44]  H. Maurer,et al.  Studies on the metabolism and the toxicological analysis of the nootropic drug fipexide in rat urine using gas chromatography-mass spectrometry. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[45]  F. Peters,et al.  Negative Ion Chemical Ionization Gas Chromatography-Mass Spectrometry and Atmospheric Pressure Chemical Ionization Liquid Chromatography-Mass Spectrometry of Low-Dosed and/or Polar Drugs in Plasma , 2002, Therapeutic drug monitoring.

[46]  P. Baumann Pharmacokinetic-Pharmacodynamic Relationship of the Selective Serotonin Reuptake Inhibitors , 1996, Clinical pharmacokinetics.

[47]  M Montagna,et al.  Fully-automated systematic toxicological analysis of drugs, poisons, and metabolites in whole blood, urine, and plasma by gas chromatography-full scan mass spectrometry. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[48]  C. Sutheimer,et al.  Detection of drugs of abuse in nails. , 1998, Journal of analytical toxicology.

[49]  P. Marquet Progress of Liquid Chromatography–Mass Spectrometry in Clinical and Forensic Toxicology , 2002, Therapeutic drug monitoring.

[50]  Timothy Olah,et al.  Mechanistic investigation of ionization suppression in electrospray ionization , 2000, Journal of the American Society for Mass Spectrometry.

[51]  R L Foltz,et al.  Ionization enhancement in atmospheric pressure chemical ionization and suppression in electrospray ionization between target drugs and stable-isotope-labeled internal standards in quantitative liquid chromatography/tandem mass spectrometry. , 2003, Rapid communications in mass spectrometry : RCM.

[52]  A. Santamaría,et al.  The action of anfepramone on neurochemical and behavioral markers in rats. , 1998, Proceedings of the Western Pharmacology Society.

[53]  P. Marquet,et al.  A general unknown screening procedure for drugs and toxic compounds in serum using liquid chromatography-electrospray-single quadrupole mass spectrometry. , 2003, Journal of analytical toxicology.

[54]  H. Maurer,et al.  Gas chromatographic-mass spectrometric procedures for determination of the catechol-O-methyltransferase (COMT) activity and for detection of unstable catecholic metabolites in human and rat liver preparations after COMT catalyzed in statu nascendi derivatization using S-adenosylmethionine. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[55]  E. Vuori,et al.  Toxicological screening of urine for drugs by liquid chromatography/time-of-flight mass spectrometry with automated target library search based on elemental formulas. , 2001, Rapid communications in mass spectrometry : RCM.

[56]  R. Clement Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites (Parts 1, 2, 3) , 1994 .

[57]  S. G. Bryant,et al.  Review of bupropion. , 1983, Clinical pharmacy.

[58]  P. Marquet Is LC-MS Suitable for a Comprehensive Screening of Drugs and Poisons in Clinical Toxicology? , 2002, Therapeutic drug monitoring.

[59]  F. Peters,et al.  Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs ('Ecstasy'). , 2000, Toxicology letters.

[60]  H. Maurer,et al.  Screening procedure for detection of non-steroidal anti-inflammatory drugs and their metabolites in urine as part of a systematic toxicological analysis procedure for acidic drugs and poisons by gas chromatography-mass spectrometry after extractive methylation. , 2001, Journal of analytical toxicology.

[61]  R. Wennig,et al.  The antispasmodic drug mebeverine leads to positive amphetamine results by fluorescence polarization immunoassay (FPIA)--studies on the toxicological analysis of urine by FPIA and GC-MS. , 2001, Journal of analytical toxicology.

[62]  R. Glennon,et al.  Methcathinone: A new and potent amphetamine-like agent , 1987, Pharmacology Biochemistry and Behavior.

[63]  H. Maurer,et al.  Identification of cytochrome P450 enzymes involved in the metabolism of 4′-methoxy-α-pyrrolidinopropiophenone (MOPPP), a designer drug, in human liver microsomes , 2003, Xenobiotica; the fate of foreign compounds in biological systems.

[64]  Pierre Marquet,et al.  Evaluation of an improved general unknown screening procedure using liquid-chromatography-electrospray-mass spectrometry by comparison with gas chromatography and high-performance liquid-chromatography—diode array detection , 2003, Journal of the American Society for Mass Spectrometry.

[65]  H. Maurer,et al.  Detection of 4-hydroxycoumarin anticoagulants and their metabolites in urine as part of a systematic toxicological analysis procedure for acidic drugs and poisons by gas chromatography-mass spectrometry after extractive methylation. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[66]  C. J. Schmitt,et al.  Validated electrospray liquid chromatographic–mass spectrometric assay for the determination of the mushroom toxins α- and β-amanitin in urine after immunoaffinity extraction , 2000 .

[67]  C. Staub,et al.  Simultaneous determination of benzodiazepines in whole blood or serum by HPLC/DAD with a semi-micro column. , 2000, Journal of pharmaceutical and biomedical analysis.

[68]  Studies on the metabolism and toxicological detection of the new designer drug N-benzylpiperazine in urine using gas , 2002 .

[69]  C. J. Schmitt,et al.  Validated electrospray liquid chromatographic-mass spectrometric assay for the determination of the mushroom toxins alpha- and beta-amanitin in urine after immunoaffinity extraction. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[70]  E Vuori,et al.  Precise gas chromatography with retention time locking in comprehensive toxicological screening for drugs in blood. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[71]  Frank T Peters,et al.  Drug testing in blood: validated negative-ion chemical ionization gas chromatographic-mass spectrometric assay for determination of amphetamine and methamphetamine enantiomers and its application to toxicology cases. , 2002, Clinical chemistry.

[72]  C. V. Van Peteghem,et al.  Suitability testing of commercial solid-phase extraction sorbents for sample clean-up in systematic toxicological analysis using liquid chromatography-(tandem) mass spectrometry. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[73]  H. Inoue,et al.  Screening and determination of benzodiazepines in whole blood using solid-phase extraction and gas chromatography/mass spectrometry. , 2000, Forensic science international.

[74]  H. Maurer,et al.  Metabolism of the new designer drug alpha-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4'-methyl-alpha-pyrrolidinopropiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometry. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[75]  H. Maurer,et al.  New designer drug 1-(3-trifluoromethylphenyl) piperazine (TFMPP): gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry studies on its phase I and II metabolism and on its toxicological detection in rat urine. , 2003, Journal of mass spectrometry : JMS.

[76]  F. Molaioni,et al.  Detection of beta-blockers in human urine by GC-MS-MS-EI: perspectives for the antidoping control. , 2000, Journal of pharmaceutical and biomedical analysis.

[77]  W. Lambert,et al.  Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: Influence of ionization type, sample preparation, and biofluid , 2003, Journal of the American Society for Mass Spectrometry.

[78]  C. Koester,et al.  Optimum methamphetamine profiling with sample preparation by solid-phase microextraction. , 2002, Journal of forensic sciences.

[79]  W. Lambert,et al.  Pitfalls associated with liquid chromatography/electrospray tandem mass spectrometry in quantitative bioanalysis of drugs of abuse in saliva. , 2001, Rapid communications in mass spectrometry : RCM.

[80]  C. Jurado,et al.  Improved solid-phase extraction method for systematic toxicological analysis in biological fluids. , 2001, Journal of analytical toxicology.

[81]  W. Weinmann,et al.  Tune compounds for electrospray ionisation/in-source collision-induced dissociation with mass spectral library searching. , 2001, Journal of chromatography. A.

[82]  F. Pragst,et al.  Use of headspace solid-phase microextraction (HS-SPME) in hair analysis for organic compounds. , 2000, Forensic science international.

[83]  R. Boulieu,et al.  Solid-Phase Microextraction of Human Plasma Samples for Determination of Sufentanil by Gas Chromatography–Mass Spectrometry , 2002, Therapeutic drug monitoring.

[84]  D. Thieme,et al.  Screening, confirmation and quantification of diuretics in urine for doping control analysis by high-performance liquid chromatography-atmospheric pressure ionisation tandem mass spectrometry. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[85]  H. Maxeiner Congestion bleedings of the face and cardiopulmonary resuscitation--an attempt to evaluate their relationship. , 2001, Forensic science international.

[86]  Y. Hirose,et al.  Quantitative analysis of tropane alkaloids in biological materials by gas chromatography-mass spectrometry. , 2002, Forensic science international.

[87]  F. Peters,et al.  Studies on the metabolism and toxicological detection of the new designer drug 4′-methyl-α-pyrrolidinopropiophenone in urine using gas chromatography–mass spectrometry , 2002 .

[88]  A. Namera,et al.  Automated headspace solid-phase microextraction and in-matrix derivatization for the determination of amphetamine-related drugs in human urine by gas chromatography-mass spectrometry. , 2002, Journal of chromatographic science.

[89]  H. Maurer,et al.  Systematic toxicological analysis procedures for acidic drugs and/or metabolites relevant to clinical and forensic toxicology and/or doping control. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[90]  H. Maurer,et al.  Screening procedure for detection of antidepressants of the selective serotonin reuptake inhibitor type and their metabolites in urine as part of a modified systematic toxicological analysis procedure using gas chromatography-mass spectrometry. , 2000, Journal of analytical toxicology.

[91]  H. Maurer,et al.  Screening procedure for detection of dihydropyridine calcium channel blocker metabolites in urine as part of a systematic toxicological analysis procedure for acidic compounds by gas chromatography-mass spectrometry after extractive methylation. , 1999, Journal of analytical toxicology.

[92]  N. Samyn,et al.  Concentrations and ratios of amphetamine, methamphetamine, MDA, MDMA, and MDEA enantiomers determined in plasma samples from clinical toxicology and driving under the influence of drugs cases by GC-NICI-MS. , 2003, Journal of analytical toxicology.

[93]  F. Peters,et al.  Screening, library-assisted identification and validated quantification of 23 benzodiazepines, flumazenil, zaleplone, zolpidem and zopiclone in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization. , 2004, Journal of mass spectrometry : JMS.

[94]  E. Richelson Pharmacokinetic interactions of antidepressants. , 1998, The Journal of clinical psychiatry.

[95]  M. Moeller,et al.  Drugs of Abuse Monitoring in Blood for Control of Driving Under the Influence of Drugs , 2002, Therapeutic drug monitoring.

[96]  F. Peters,et al.  Validated assay for quantification of oxcarbazepine and its active dihydro metabolite 10-hydroxycarbazepine in plasma by atmospheric pressure chemical ionization liquid chromatography/mass spectrometry. , 2002, Journal of mass spectrometry : JMS.

[97]  H. Maurer,et al.  New designer drug 1-(3,4-methylenedioxybenzyl) piperazine (MDBP): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry. , 2004, Journal of mass spectrometry : JMS.

[98]  J. Segura,et al.  Fast screening of anabolic steroids and other banned doping substances in human urine by gas chromatography/tandem mass spectrometry. , 2002, Journal of mass spectrometry : JMS.

[99]  J. Ahlner,et al.  A2 (N-benzylpiperazine) a new drug of abuse in Sweden. , 2004, Journal of analytical toxicology.

[100]  P. Marquet,et al.  Methods for the determination of seven selective serotonin reuptake inhibitors and three active metabolites in human serum using high-performance liquid chromatography and gas chromatography. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[101]  W. Thormann Progress of capillary electrophoresis in therapeutic drug monitoring and clinical and forensic toxicology. , 2002, Therapeutic drug monitoring.

[102]  D. Deforce,et al.  Liquid chromatography-mass spectrometry in forensic toxicology. , 2000, Mass spectrometry reviews.

[103]  E Vuori,et al.  Simultaneous screening for 238 drugs in blood by liquid chromatography-ion spray tandem mass spectrometry with multiple-reaction monitoring. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[104]  I. Vernaleken,et al.  Studies on the metabolism and toxicological detection of the amphetamine-like anorectic mefenorex in human urine by gas chromatography-mass spectrometry and fluorescence polarization immunoassay. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[105]  M. Chiarotti,et al.  SPME-GC analysis of THC in saliva samples collected with "EPITOPE" device. , 2001, Forensic science international.

[106]  J. Valentine,et al.  GC-MS identification of sympathomimetic amine drugs in urine: rapid methodology applicable for emergency clinical toxicology. , 2000, Journal of analytical toxicology.

[107]  E. Vuori,et al.  Toxicological screening with formula-based metabolite identification by liquid chromatography/time-of-flight mass spectrometry. , 2003, Analytical chemistry.

[108]  F. Peters,et al.  Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. , 2003, Journal of mass spectrometry : JMS.

[109]  R. Ventura,et al.  Derivatization procedures for gas chromatographic-mass spectrometric determination of xenobiotics in biological samples, with special attention to drugs of abuse and doping agents. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[110]  O. Drummer,et al.  Postmortem Drug Analysis: Analytical and Toxicological Aspects , 2002, Therapeutic drug monitoring.

[111]  H. Maurer Role of Gas Chromatography–Mass Spectrometry With Negative Ion Chemical Ionization in Clinical and Forensic Toxicology, Doping Control, and Biomonitoring , 2002, Therapeutic drug monitoring.

[112]  H. Maurer,et al.  Studies on the metabolism and toxicological detection of the Eschscholtzia californica alkaloids californine and protopine in urine using gas chromatography-mass spectrometry. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[113]  W. Lambert,et al.  Evaluation of automated single mass spectrometry to tandem mass spectrometry function switching for comprehensive drug profiling analysis using a quadrupole time-of-flight mass spectrometer. , 2000, Rapid communications in mass spectrometry : RCM.

[114]  K. Tomlinson,et al.  The simultaneous determination of codeine, morphine, hydrocodone, hydromorphone, 6-acetylmorphine, and oxycodone in hair and oral fluid. , 2002, Journal of analytical toxicology.

[115]  Laurent Rivier,et al.  Criteria for the identification of compounds by liquid chromatography–mass spectrometry and liquid chromatography–multiple mass spectrometry in forensic toxicology and doping analysis , 2003 .

[116]  Fred W. McLafferty,et al.  Registry of mass spectral data , 1974 .

[117]  N. Samyn,et al.  Use of Alternative Specimens: Drugs of Abuse in Saliva and Doping Agents in Hair , 2002, Therapeutic drug monitoring.

[118]  H. Maurer,et al.  Metabolism and toxicological detection of the new designer drug 4'-methoxy-alpha-pyrrolidinopropiophenone studied in rat urine using gas chromatography-mass spectrometry. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[119]  J. Ager,et al.  Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis. , 2001, The Journal of pediatrics.

[120]  A. Namera,et al.  Highly sensitive analysis of methamphetamine and amphetamine in human whole blood using headspace solid-phase microextraction and gas chromatography-mass spectrometry. , 2001, Forensic science international.

[121]  T. Kumazawa,et al.  Determination of phenothiazines in human body fluids by solid-phase microextraction and liquid chromatography/tandem mass spectrometry. , 2000, Journal of mass spectrometry : JMS.

[122]  S. Stanley,et al.  Large-volume injection gas chromatography-mass spectrometry for automated broad-spectrum drug screening in horse urine. , 2003, Journal of analytical toxicology.

[123]  M. Thevis,et al.  High speed determination of beta-receptor blocking agents in human urine by liquid chromatography/tandem mass spectrometry. , 2001, Biomedical chromatography : BMC.

[124]  F. Peters,et al.  Screening, library-assisted identification and validated quantification of oral antidiabetics of the sulfonylurea-type in plasma by atmospheric pressure chemical ionization liquid chromatography-mass spectrometry. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[125]  K. Deventer,et al.  Screening for 18 diuretics and probenecid in doping analysis by liquid chromatography-tandem mass spectrometry. , 2002, Biomedical chromatography : BMC.

[126]  J M Hough,et al.  Evaluation of electrospray transport CID for the generation of searchable libraries. , 2000, Analytical chemistry.

[127]  S. Ferrara,et al.  Determination of midazolam in human plasma by solid-phase microextraction and gas chromatography/mass spectrometry. , 2001, Rapid communications in mass spectrometry : RCM.

[128]  K. Rentsch,et al.  [Fatal brain edema after ingestion of ecstasy and benzylpiperazine]. , 2001, Deutsche medizinische Wochenschrift.

[129]  E. Kenndler,et al.  Determination of 1,2,4-trimethylbenzene (pseudocumene) in serum of a person exposed to liquid scintillation counting solutions by GC/MS. , 1989, Journal of analytical toxicology.

[130]  T. Annesley Ion suppression in mass spectrometry. , 2003, Clinical chemistry.

[131]  F. Erdmann,et al.  Simultaneous screening and detection of drugs in small blood samples and bloodstains. , 2002, Forensic science international.

[132]  O. Temme,et al.  An analytical method for the rapid screening of organophosphate pesticides in human biological samples and foodstuffs. , 2001, Forensic science international.

[133]  S. Pollak,et al.  Automated solid-phase extraction and two-step derivatisation for simultaneous analysis of basic illicit drugs in serum by GC/MS , 2000, International Journal of Legal Medicine.

[134]  W. Lambert,et al.  Simultaneous determination of in total 17 opium alkaloids and opioids in blood and urine by fast liquid chromatography-diode-array detection-fluorescence detection, after solid-phase extraction. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[135]  A. Polettini,et al.  Comprehensive Drug Screening by Integrated Use of Gas Chromatography/Mass Spectrometry and Remedi HS , 2001, Therapeutic drug monitoring.

[136]  F. Pragst,et al.  Screening method for seventy psychoactive drugs or drug metabolites in serum based on high-performance liquid chromatography--electrospray ionization mass spectrometry. , 2001, Journal of analytical toxicology.

[137]  H. Maurer,et al.  Metabolism and toxicological detection of the new designer drug 3′,4′-methylenedioxy-α-pyrrolidinopropiophenone studied in urine using gas chromatography–mass spectrometry , 2003 .

[138]  W. Külpmann,et al.  High-temperature solid-phase microextraction procedure for the detection of drugs by gas chromatography-mass spectrometry. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[139]  R. Fokkens,et al.  Methodology for the development of a drug library based upon collision-induced fragmentation for the identification of toxicologically relevant drugs in plasma samples. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[140]  Frank T Peters,et al.  Amphetamine concentrations in human urine following single-dose administration of the calcium antagonist prenylamine-studies using fluorescence polarization immunoassay (FPIA) and GC-MS. , 2003, Journal of analytical toxicology.

[141]  K. Hara,et al.  New method of derivatization and headspace solid-phase microextraction for gas chromatographic-mass spectrometric analysis of amphetamines in hair. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[142]  T. Shinohara,et al.  Systematic analysis of acid, neutral and basic drugs in horse plasma by combination of solid-phase extraction, non-aqueous partitioning and gas chromatography-mass spectrometry. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[143]  L. Benet,et al.  Acyl glucuronides revisited: is the glucuronidation process a toxification as well as a detoxification mechanism? , 1992, Drug metabolism reviews.

[144]  F. Musshoff,et al.  Fully automated determination of cannabinoids in hair samples using headspace solid-phase microextraction and gas chromatography-mass spectrometry. , 2002, Journal of analytical toxicology.

[145]  W. Lambert,et al.  Comparison of phenyl-type columns in the development of a fast liquid chromatographic system for eighteen opiates commonly found in forensic toxicology. , 2000, Journal of chromatography. A.

[146]  P. Marquet,et al.  Sensitive and specific multiresidue methods for the determination of pesticides of various classes in clinical and forensic toxicology. , 2001, Forensic science international.

[147]  I. Bosman,et al.  Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market. , 2001, Forensic science international.